Journal of Pharmaceutical Policy and Practice

Show Articles
Journal Properties
  • Country
    United Kingdom
  • Language
    English
  • Number of Articles
    805
  • Abbreviation
    J Pharm Policy Pract
  • e-ISSN
    2052-3211
  • Publisher
    Informa UK Limited
  • Indian UGC
  • DOAJ (latest)
Journal Properties
  • Final Decision (day)
    98
  • Medicine
    Pharmacy and materia medica
    Medicine
    Public aspects of medicine
    Medicine
    Therapeutics
    Pharmacology
  • website
Description
The Journal of Pharmaceutical Policy and Practice is an open-access, peer-reviewed journal dedicated to exploring the intersection of pharmaceutical policies and their real-world impact. It offers a platform for researchers, policymakers, and practitioners to discuss and analyze the development, implementation, and evaluation of pharmaceutical policies across different healthcare systems. This journal encompasses a wide array of topics, including drug pricing and reimbursement, access to medicines, pharmaceutical regulation, pharmacovigilance, and the role of pharmacists in healthcare delivery. It welcomes original research articles, systematic reviews, policy analyses, and commentaries that contribute to a better understanding of the challenges and opportunities in pharmaceutical policy and practice. The journal's target audience includes health economists, pharmacists, policymakers, regulators, and researchers in the field of pharmaceutical sciences. The journal articles are often indexed in Scopus, PubMed Central, and other recognized databases. By providing a forum for evidence-based discussions, the Journal of Pharmaceutical Policy and Practice aims to inform decision-making and promote the development of effective pharmaceutical policies that improve patient outcomes and ensure sustainable healthcare systems. Authors are invited to submit their high-quality research and contribute to this important dialogue.
Directory of Open Access Journals (DOAJ)
There is further information about this journal. Please follow links.